New Delhi Chief Minister Arvind Kejriwal on Friday said the Delhi government will not stop clinical trials of plasma therapy to treat severally-ill COVID-19 patients as its initial results are good.
The announcement came days after the centre said that plasma therapy for the treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complications.
Addressing an online media briefing, Kejriwal said that one patient, whose condition was serious, has been discharged from hospital after undergoing plasma therapy.
"We are not going to stop clinical trials of plasma therapy. We are getting good results for the therapy. However, it is on a trial basis," he said.
They are contacting 1,100 people who have recovered from COVID-19 to donate their plasma to save lives, he added.